drug

pemivibart

Marketedupdated 5mo ago

by $IVVD Invivyd, Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying pemivibart

phase3A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2completedn=790

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

pemivibart

Marketedupdated 5mo ago

by $IVVD Invivyd, Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying pemivibart

phase3A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2completedn=790

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

pemivibart

all catalysts(0)

Trials studying pemivibart

News(0)

Report a data issue

comments(0)

pemivibart

all catalysts(0)

Trials studying pemivibart

News(0)

Report a data issue

comments(0)